UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Malignancies in the setting of primary immunodeficiency: Implications for hematologists/oncologists

American journal of hematology, 2011-01, Vol.86 (1), p.48-55

Shapiro, Ralph S.

2011

Volltextzugriff (PDF)

Subcutaneous immunoglobulin therapy given by subcutaneous rapid push vs infusion pump: a retrospective analysis

Annals of allergy, asthma, & immunology, 2013-07, Vol.111 (1), p.51-55

Shapiro, Ralph S., MD

2013

Volltextzugriff (PDF)

Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics

Pediatric allergy and immunology, 2013-02, Vol.24 (1), p.49-53

Shapiro, Ralph S.

2013

Volltextzugriff (PDF)

Why I Use Subcutaneous Immunoglobulin (SCIG)

Journal of clinical immunology, 2013, Vol.33 (Suppl 2), p.95-98

Shapiro, Ralph S.

2013

Volltextzugriff (PDF)

Supplement: Frontiers in Immunoglobulin Therapy of Primary Immunodeficiency Disease

Journal of clinical immunology, 2017-02, Vol.37 (2), p.187-187

Shapiro, Ralph S.

2017

Volltextzugriff (PDF)

Emerging Paradigm of Primary Immunodeficiency Disease: Individualizing Immunoglobulin Dose and Delivery to Enhance Outcomes

Journal of clinical immunology, 2017-02, Vol.37 (2), p.190-196

2017

Volltextzugriff (PDF)

Facilitating home-based treatment of hereditary angioedema

Allergy and asthma proceedings, 2015-03, Vol.36 (2), p.92-99

2015

Volltextzugriff (PDF)

Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies

Frontiers in immunology, 2021-07, Vol.12, p.707463-707463

2021

Volltextzugriff (PDF)

Training hereditary angioedema patients to self-administer intravenous C1 esterase inhibitor concentrate

Journal of infusion nursing, 2014-07, Vol.37 (4), p.284-290

2014

Volltextzugriff (PDF)

Construction and validation of a novel disease-specific quality-of-life instrument for patients with primary antibody deficiency disease (PADQOL-16)

Journal of allergy and clinical immunology, 2017-06, Vol.139 (6), p.2007-2010.e8

2017

Volltextzugriff (PDF)

Payor Issues: Barriers to Optimal Management of Patients with Primary Immunodeficiency

Journal of clinical immunology, 2012-09, Vol.32 (Suppl 2), p.410-414

2012

Volltextzugriff (PDF)

Subcutaneous Immunoglobulin

Immunology and allergy clinics of North America, 2012-07

Shapiro, Ralph, MD

2012

Volltextzugriff (PDF)

Subcutaneous Immunoglobulin Therapy by Rapid Push is Preferred to Infusion by Pump: A Retrospective Analysis

Journal of clinical immunology, 2010-03, Vol.30 (2), p.301-307

Shapiro, Ralph

2010

Volltextzugriff (PDF)

Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema

Annals of allergy, asthma, & immunology, 2017-01, Vol.118 (1), p.110-112

2017

Volltextzugriff (PDF)

Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2016-09, Vol.4 (5), p.963-971

2016

Volltextzugriff (PDF)

Efficacy and Safety of an Intravenous C1-Inhibitor Concentrate for Long-Term Prophylaxis in Hereditary angioedema

Allergy & rhinology (Providence, R.I.), 2017-03, Vol.8 (1), p.13-19

2017

Volltextzugriff (PDF)

Clinical Ambiguities—Ongoing Questions

Journal of clinical immunology, 2013, Vol.33 (Suppl 2), p.99-103

2013

Volltextzugriff (PDF)

Local and National Advocacy Support

Journal of clinical immunology, 2012-09, Vol.32 (Suppl 2), p.423-426

2012

Volltextzugriff (PDF)

Improved IgG3 levels and reduced infection rate in a woman with CVID switched from intravenous to subcutaneous immunoglobulin therapy

Immunotherapy, 2012-12, Vol.4 (12), p.1835-1839

Shapiro, Ralph S

2012

Volltextzugriff (PDF)

Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2017-07, Vol.5 (4), p.1142-1145

2017

Volltextzugriff (PDF)

Construction and Validation of a Health-Related Quality of Life (HR-QOL) Instrument for Patients with Primary Antibody Deficiency Disease

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB221-AB221

2016

Volltextzugriff (PDF)

Efficacy and Safety of a C1 Esterase Inhibitor Concentrate for Long-Term Prophylaxis in Hereditary Angioedema: Findings from a Large International Registry

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB193-AB193

2015

Volltextzugriff (PDF)

Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2018-11, Vol.320 (20), p.2108

2018

Volltextzugriff (PDF)

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

The New England journal of medicine, 1989-10, Vol.321 (16), p.1080-1085

1989

Volltextzugriff (PDF)

An essential role for the Zn2+ transporter ZIP7 in B cell development

Nature immunology, 2019-03, Vol.20 (3), p.350-361

2019

Volltextzugriff (PDF)

1 – 25 von 328

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(272)
Mit Volltextzugriff
(243)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(327)
Deutsch
(1)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Malignancies in the setting of primary immunodeficiency: Implications for hematologists/oncologists

Subcutaneous immunoglobulin therapy given by subcutaneous rapid push vs infusion pump: a retrospective analysis

Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics

Why I Use Subcutaneous Immunoglobulin (SCIG)

Supplement: Frontiers in Immunoglobulin Therapy of Primary Immunodeficiency Disease

Emerging Paradigm of Primary Immunodeficiency Disease: Individualizing Immunoglobulin Dose and Delivery to Enhance Outcomes

Facilitating home-based treatment of hereditary angioedema

Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies

Training hereditary angioedema patients to self-administer intravenous C1 esterase inhibitor concentrate

Construction and validation of a novel disease-specific quality-of-life instrument for patients with primary antibody deficiency disease (PADQOL-16)

Payor Issues: Barriers to Optimal Management of Patients with Primary Immunodeficiency

Subcutaneous Immunoglobulin

Subcutaneous Immunoglobulin Therapy by Rapid Push is Preferred to Infusion by Pump: A Retrospective Analysis

Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema

Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data

Efficacy and Safety of an Intravenous C1-Inhibitor Concentrate for Long-Term Prophylaxis in Hereditary angioedema

Clinical Ambiguities—Ongoing Questions

Local and National Advocacy Support

Improved IgG3 levels and reduced infection rate in a woman with CVID switched from intravenous to subcutaneous immunoglobulin therapy

Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients

Construction and Validation of a Health-Related Quality of Life (HR-QOL) Instrument for Patients with Primary Antibody Deficiency Disease

Efficacy and Safety of a C1 Esterase Inhibitor Concentrate for Long-Term Prophylaxis in Hereditary Angioedema: Findings from a Large International Registry

Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

An essential role for the Zn2+ transporter ZIP7 in B cell development

Suchergebnisse filtern